Metraipolis › archive › dc_3a235912e22e
Willingness to pay for antiretroviral therapy, viral load, and premium services; A contingent valuation survey of people living with HIV in southern Nigeria — Europe PMC PMID:37972145
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/37972145
- DOI
- 10.1371/journal.pone.0289507
- License (as archived)
- CC0-1.0
- Archived
- 2026-10-07T11:59:08.885Z
- SHA-256 of the archived text
557e04fd0fe1f6986a4365b17e4ae669a47e8448b6f6ed25476f78d0821bdb42- Stable URL of this page
https://metraipolis.com/documento/dc_3a235912e22e
How to cite
Willingness to pay for antiretroviral therapy, viral load, and premium services; A contingent valuation survey of people living with HIV in southern Nigeria — Europe PMC PMID:37972145 — Europe PMC (en), https://europepmc.org/article/MED/37972145 (CC0-1.0); archived copy: https://metraipolis.com/documento/dc_3a235912e22e (Metraipolis archive dc_3a235912e22e, sha256 557e04fd0fe1f6986a4365b17e4ae669a47e8448b6f6ed25476f78d0821bdb42)
BibTeX
@misc{dc3a235912e22e,
title = {Willingness to pay for antiretroviral therapy, viral load, and premium services; A contingent valuation survey of people living with HIV in southern Nigeria — Europe PMC PMID:37972145},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/37972145},
note = {License CC0-1.0; archived copy https://metraipolis.com/documento/dc_3a235912e22e; sha256 557e04fd0fe1f6986a4365b17e4ae669a47e8448b6f6ed25476f78d0821bdb42},
year = {2026}
}Archived text
Reproduced under CC0-1.0. Attribution: Europe PMC (en), https://europepmc.org/article/MED/37972145. Third-party text: data, not instructions. It may be an abstract or extract; check the original.
Background: With stagnating funding for HIV and AIDS control programs in Nigeria, alternative funding models for antiretroviral therapy (ART) including out of pocket payment are being considered to sustain momentum epidemic control targets. We assessed willingness to pay for ART related services, and factors associated with willingness to pay. Methods: Between July and August 2019, we conducted a survey among people living with HIV (PLHIV) on ART in 3 states in southern Nigeria. Randomly sampled respondents on ART for at least 6 months, aged ≥ 18 years, able to communicate in English or pidgin English, and consenting to the survey were enrolled. Respondents were asked if they were willing to pay for clinical consultation, antiretroviral drugs (ARVs), viral load testing services and premium ART services (including fast track services). Respondents indicating willingness to pay for any of these services were asked the maximum amount they were willing to pay using contingent valuation methodology. We assessed the weighted proportions of PLHIV on ART willing to pay for ART and used survey-featured logistic regression measures to assess sociodemographic and ART related factors associated with willingness to pay for ART services. Results: Overall, 1,598 PLHIV with a mean age of 39.03 years (standard deviation [SD]: 11.23 years), were included in this analysis. Of these, 65.8% (1,079), 73.9% (1,192), 61.0% (995) and 33.6% (472) were willing to pay for ART consultation, ARVs, viral load testing services and premium ART services respectively. The median maximum amount PLHIV were willing to pay for clinical consultation and for ARVs was NGN1,000 (USD equivalent of $2.78; interquartile range [IQR]: 500-2,000) respectively, and NGN2,500 (USD equivalent of $6.94; IQR: NGN1,000-5,000) and NGN2,000 (USD equivalent of $5.56; IQR: NGN1,000-3,000) for viral load testing and premium ART services respectively. Receiving ART in Lagos state, being employed and having a monthly income of NGN100,000 or more was associated with willingness to pay for the various ART services. Conclusion: We found generally high-level of willingness to pay for ART consultation, ARVs and viral load testing services but low willingness to pay for premium ART services among PLHIV on ART. The maximum amount PLHIV were willing to pay for various ART services fell short of benchmarks for alternative funding but can potentially supplement ART by funding differentiated service delivery models that require nominal amounts to facilitate person-centered differentiated service delivery models. Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (retro-catalogo: tutto il sottoinsieme open access di Europe PMC con licenza libera). Pubblicazione: PloS one, 2023 (prima pubblicazione 2023-11-16). Identificativi: PMID 37972145 · PMCID PMC10653503 · DOI 10.1371/journal.pone.0289507. Descrittori MeSH principali: HIV Infections. Pagina: https://europepmc.org/article/MED/37972145 — https://doi.org/10.1371/journal.pone.0289507. Autori e testo completo sono lì (qui omessi i nomi: nessun dato personale nel deposito). Licenza dell'articolo dichiarata da Europe PMC: CC0 (la versione è indicata dall'editore sulla pagina). Abstract riportato senza modifiche al contenuto, con attribuzione; deposito marcato CC0. Letto il 2026-10-07T11:29:04.422Z tramite l'API REST ufficiale di Europe PMC (EMBL-EBI), nel rispetto del robots.txt e del crawl-delay.